Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years’ follow-up
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The burden of type 2 diabetes is growing, not only through increased incidence, but also through its comorbidities. Concordant comorbidities for type 2 diabetes, such as cardiovascular diseases, are considered expected outcomes of the disease or disease complications, while discordant comorbidities are not considered to be directly related to type 2 diabetes and are less extensively addressed under diabetes management. Here we show that the combination of concordant and discordant comorbidities appears frequently in persons with diabetes (75%). Persons with combined comorbidities visited family physicians more than persons with discordant, concordant or no comorbidity (17.3 ± 10.2, 11.6 ± 6.5, 8.7 ± 6.8, 6.3 ± 6.6 visits/person/year respectively, p < 0.0001). The risk of death during the study period was highest in persons with combined comorbidities and discordant only comorbidities (HR = 33.4; 95% CI 12.5–89.2 and HR = 33.5; 95% CI 11.7–95.8), emphasizing the contribution of discordant comorbidities to the outcome. Our study is unique as a long-term follow-up of an 11-year cohort of 9725 persons with new-onset type 2 diabetes. The findings highlight the contribution of discordant comorbidity to the burden of the disease. The high prevalence of the combination of both concordant and discordant comorbidities, and their appearance before the onset of type 2 diabetes, indicates a continuum of morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, sustained weight reduction can help to defer the onset and reduce the progression of these co-morbidities [68-71].”
From Recent advances in peptide-based therapies for obesity and type 2 diabetes (2024) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Excess Mortality among Persons with Type 2 Diabetes
Tancredi, M., Rosengren, A., Svensson, A.-M., Kosiborod, M., Pivodic, A., Gudbjörnsdottir, S., Wedel, H., Clements, M., Dahlqvist, S., & Lind, M. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504347 · Cited by 996
Samson, S. L., & Garber, A. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.009 · Cited by 746
The Impact of Comorbid Chronic Conditions on Diabetes Care
Piette, J. D., & Kerr, E. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-2078 · Cited by 731
Gregg, E. W., Cheng, Y. J., Srinivasan, M., Lin, J., Geiss, L. S., Albright, A. L., & Imperatore, G. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30314-3 · Cited by 480
Dall, T. M., Yang, W., Gillespie, K., Mocarski, M., Byrne, E., Cintina, I., Beronja, K., Semilla, A. P., Iacobucci, W., & Hogan, P. F. (2019) · Diabetes Care · doi:10.2337/dc18-1226 · Cited by 438
Evidence on multimorbidity from definition to intervention: An overview of systematic reviews
Xu, X., Mishra, G. D., & Jones, M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.003 · Cited by 397
Dall, T. M., Yang, W., Halder, P., Pang, B., Massoudi, M., Wintfeld, N., Semilla, A. P., Franz, J., & Hogan, P. F. (2014) · Diabetes Care · doi:10.2337/dc14-1036 · Cited by 382
Kerr, E. A., Heisler, M., Krein, S. L., Kabeto, M., Langa, K. M., Weir, D., & Piette, J. D. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0313-2 · Cited by 330
Research works printed but not linked: 1
- Cohen, R. & Rabin, G. National Insurance Institute R and PA. Membership in sick funds 2016 [Hebrew]. Period Surv. 289, 4 (2017).
Cited by
Yang, S., Sun, Y., & Yan, C. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02603-4 · Cited by 127
Recent advances in peptide-based therapies for obesity and type 2 diabetes
Bailey, C. J., Flatt, P. R., & Conlon, J. M. (2024) · Peptides · doi:10.1016/j.peptides.2024.171149 · Cited by 25
The Effect of Diabetes on Complications after Spinal Fusion: A Systematic Review and Meta-Analysis
Ruggiero, N., Soliman, M. A. R., Kuo, C. C., Aguirre, A. O., Quiceno, E., Saleh, J., Yeung, K., Khan, A., Hess, R. M., Lim, J., et al. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.03.008 · Cited by 12
Wamil, M., Hassaïne, A., Rao, S., Li, Y., Mamouei, M., Canoy, D., Nazarzadeh, M., Bidel, Z., Copland, E., Rahimi, K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-38251-1 · Cited by 14
Negussie, Y. M., Getahun, M. S., & Bekele, N. T. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1307463 · Cited by 9
Metadata
- Authors
- Eilat-Tsanani, S., Margalit, A., & Golan, L. N.
- Affiliations
- Bar-Ilan University (IL)
- Venue
- Scientific Reports
- Published
- 2021-05-26
- Volume
- 11
- Issue
- 1
- Pages
- 11071-11071
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC8155151
- OpenAlex
- W3165029143
- Cited by
- 28
- References
- 33
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 7 · 2023: 6 · 2022: 1
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Clalit Health Services
- Topics
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, comorbidities, cardiovascular disease, mortality risk, family physician visits, newly diagnosed diabetes, long-term follow-up, disease burden
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Comorbidity, Incidence, Prevalence, Age of Onset, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years’ follow-up. https://app.cochat.ai/papers/10.1038/s41598-021-90379-0
- The paper
- Eilat-Tsanani, S., Margalit, A., & Golan, L. N. (2021). Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years’ follow-up. Scientific Reports. https://doi.org/10.1038/s41598-021-90379-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.